Mantziari Styliani, Allemann Pierre, Winiker Michael, Demartines Nicolas, Schäfer Markus
Department of Visceral Surgery and Transplantation, Lausanne University Hospital (CHUV), Rue du Bugnon 46, 1011, Lausanne, Switzerland.
World J Surg. 2018 Jul;42(7):2209-2217. doi: 10.1007/s00268-017-4422-8.
Tumor recurrence during the first year after oncological esophagectomy has been reported in up to 17-66% of patients. However, little is known as to the risk factors potentially associated with this adverse outcome. The aim of this retrospective observational study was to identify clinically relevant parameters associated with early recurrence.
All patients with squamous cell cancer or adenocarcinoma of the esophagus or gastroesophageal junction, operated with curative intent in our center from 2000 to 2014, were screened for this study. Univariate analysis was conducted to identify variables potentially associated with early recurrence, and clinically relevant parameters with P < 0.1 were included in multiple logistic regression. Survival analyses were conducted with the Kaplan-Meier method. Significance threshold was set at P < 0.05.
Among the 164 included patients, 46 (28%) presented early recurrence. Eight patients (17.4%) had locoregional and 38 patients (82.6%) metastatic recurrence. Advanced T and N stages, lymph node capsular effraction, a high positive-to-resected lymph node ratio, positive resection margins, poor response to neoadjuvant treatment, preoperative active smoking, malnutrition and dysphagia were associated with early recurrence on a univariate level. In multivariable analysis, preoperative smoking (OR 2.76, 95% CI 1.28-6.17), pT stage (OR 1.72, 95% CI 1.18-2.58) and an increased positive-to-resected lymph node ratio (OR 6.72, 95% CI 1.08-48.51) remained independently associated with ER.
Our study identified both patient- and tumor-related parameters as risk factors for early recurrence after oncological esophagectomy. Of particular interest, active smoking was significantly associated with this adverse outcome, highlighting the importance of preoperative smoking cessation.
据报道,肿瘤性食管切除术后第一年的肿瘤复发率在17%至66%的患者中出现。然而,对于可能与这种不良结局相关的危险因素知之甚少。这项回顾性观察研究的目的是确定与早期复发相关的临床相关参数。
对2000年至2014年在本中心接受根治性手术的所有食管鳞状细胞癌、腺癌或胃食管交界癌患者进行本研究筛查。进行单因素分析以确定可能与早期复发相关的变量,P<0.1的临床相关参数纳入多因素逻辑回归。采用Kaplan-Meier法进行生存分析。显著性阈值设定为P<0.05。
在纳入的164例患者中,46例(28%)出现早期复发。8例(17.4%)为局部区域复发,38例(82.6%)为远处转移复发。在单因素水平上,T和N分期较晚、淋巴结包膜侵犯、阳性淋巴结与切除淋巴结的比例较高、手术切缘阳性、新辅助治疗反应不佳、术前主动吸烟、营养不良和吞咽困难与早期复发相关。在多因素分析中,术前吸烟(OR 2.76,95%CI 1.28-6.17)、pT分期(OR 1.72,95%CI 1.18-2.58)和阳性淋巴结与切除淋巴结比例增加(OR 6.72,95%CI 1.08-48.51)仍与早期复发独立相关。
我们的研究确定了患者和肿瘤相关参数均为肿瘤性食管切除术后早期复发的危险因素。特别值得注意的是,主动吸烟与这种不良结局显著相关,突出了术前戒烟的重要性。